miR-183 inhibits the viability, migration and invasion of epithelium on adenomyosis via targeting MMP-9
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This study investigated how miR-183 impacts adenomyosis by targeting MMP-9, finding that it inhibits the viability, migration, and invasion of epithelial cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BackgroundAdenomyosis refers to a pathological damage resulting from local and diffuse lesions in endometrium, caused by invasive endometrial gland and its mesenchyme. Our study aimed to reveal miR-183's role in the development of adenomyosis.MethodsIn this context, we separated the epithelium cells of patients with adenomyosis, detected matrix metalloprotein 9 (MMP-9) expression by immunohistochemistry (IHC), and then treated them separately with miR-183 over-expression and miR-183 interference. The effects on epithelium cells funcions with transfections were evaluated by cell viability, migration and invasion assays. Based on that observation, we conducted double luciferase reporting system detection to the screening and the validation of miR-183's target genes.ResultsIt turned out that miR-183 over-expression had a powerful repressive effect on epithelium's viability, migration and invasion; however, the interference in miR-183 contributed a reverse result. Our dual-luciferase assay confirmed that MMP-9 is a target gene of miR-183 in endometrial tissue. Immunohistochemical staining reconfirmed that the fact that MMP-9 was highly expressed in the endometrial tissue of adenomyosis. Importantly, we found that the miR-183 expression in the endometrial tissue of adenomyosis was distinctly lower than normal endometrium.ConclusionIn general, we are the first to disclose the distinction of miR-183 and MMP-9 expressions in adenomyosis after we elucidated miR-183's role in epithelium's viability, migration and invasion .
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- [A STUDY OF UTERINE HEMODYNAMICS USING THREE-DIMENSIONAL POWER DOPPLER SONOGRAPHY IN PATIENTS WITH ADENOMYOSIS]. via openalex
- Defective myometrial spiral artery remodelling as a cause of major obstetrical syndromes in endometriosis and adenomyosis via openalex
- Diagnosis of endometriosis 2nd part - Ultrasound diagnosis of endometriosis (adenomyosis, endometriomas, adhesions) in the community. via openalex
- Differential expression and inhibitory effects of aquaporins on the development of adenomyosis via openalex
- Experimental adenomyosis via openalex
- Matrix Metalloproteinase-2 and -9 Expression Correlated with Angiogenesis in Human Adenomyosis via openalex
- Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review via openalex
- Role of Hormones in Common Benign Uterine Lesions: Endometrial Polyps, Leiomyomas, and Adenomyosis via openalex
- [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis]. via openalex
- The Pathogenesis of Adenomyosis vis-à-vis Endometriosis via openalex
- W2911725508 via openalex
- W6716689614 via openalex
- W6754132290 via openalex
- W6771114944 via openalex
- W6772476631 via openalex
- W6782347299 via openalex
- W2095159968 via openalex
- W2100258830 via openalex
- W2266659175 via openalex
- W2572077158 via openalex
- W2573970795 via openalex
- W2594321122 via openalex
- W2889788690 via openalex
- W2898364729 via openalex
- W2901068426 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-09-12T06:55:35.949492+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:23:57.700195+00:00
- unpaywall
- last seen: 2026-09-12T07:21:10.926195+00:00
License: CC0
· commercial use OK